MUC1 and systemic sclerosis: One of the potential reasons for the lack of a correlation between short-term changes in KL-6 levels and subsequent ILD progression in our patients was a low frequency of patients with ILD progression: only 3% of the patients with SSc-ILD experienced a relative decline in FVC ≥ 10% over one year.